European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of multifocal motor neuropathy. Report of a Joint Task Force of the European Federation of Neurological Societies and the Peripheral Nerve Society – first revision

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of the peripheral nervous system

• Publication date

  2010-12-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1111/j.1529-8027.2010.00290.xPMID 21199100
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Activity‐dependent conduction block in multifocal motor neuropathy

  2011cited by this paper
• IVIg dose increase in multifocal motor neuropathy

  2009cited by this paper
• Sensory loss in multifocal motor neuropathy: A clinical and electrophysiological study

  2009cited by this paper
• Immunosuppressant and immunomodulatory treatments for multifocal motor neuropathy.

  2009cited by this paper
• Subcutaneous immunoglobulin therapy for multifocal motor neuropathy

  2009cited by this paper
• Beneficial effect of rituximab monotherapy in multifocal motor neuropathy.

  2009cited by this paper
• [Multifocal motor neuropathy: a retrospective study of sensory nerve conduction velocities in long-term follow-up of 21 patients].

  2009cited by this paper
• Subcutaneous versus intravenous immunoglobulin in multifocal motor neuropathy: a randomized, single‐blinded cross‐over trial

  2009cited by this paper
• Oral methotrexate as adjunctive therapy in patients with multifocal motor neuropathy on chronic IVIg therapy

  2009cited by this paper
• The clinical value of therapeutic plasma exchange in multifocal motor neuropathy.

  2008cited by this paper
• Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial.

  2007cited by this paper
• Rituximab treatment in patients with IVIg‐dependent immune polyneuropathy: A prospective pilot trial

  2007cited by this paper
• Multifocal motor neuropathy

  2007cited by this paper
• Multifocal motor neuropathy with and without conduction block: A single entity?

  2007cited by this paper
• Intravenous immunoglobulin as short- and long-term therapy of multifocal motor neuropathy: a retrospective study of response to IVIg and of its predictive criteria in 40 patients

  2007cited by this paper
• Multifocal motor neuropathy with and without conduction block

  2006cited by this paper
• Axon loss is an important determinant of weakness in multifocal motor neuropathy

  2006cited by this paper
• Criteria for conduction block based on computer simulation studies of nerve conduction with human data obtained in the forearm segment of the median nerve.

  2006cited by this paper
• Activity-dependent conduction block in multifocal motor neuropathy

  2006cited by this paper
• Multifocal motor neuropathy

  2006cited by this paper
• Multifocal motor neuropathy: Current concepts and controversies

  2005cited by this paper
• Neurologic services in the nations of Africa

  2005cited by this paper
• Intravenous immunoglobulin for multifocal motor neuropathy.

  2005cited by this paper
• Rituximab stabilizes multifocal motor neuropathy increasingly less responsive to IVIg

  2004cited by this paper
• Guidance for the preparation of neurological management guidelines by EFNS scientific task forces – revised recommendations 2004 *

  2004cited by this paper
• How long is IVIg effective in multifocal motor neuropathy?

  2004cited by this paper
• Multifocal motor neuropathy

  2004cited by this paper
• Chronic neuropathy with IgM anti-ganglioside antibodies: Lack of long term response to rituximab

  2003cited by this paper
• Demyelination and axonal loss in multifocal motor neuropathy: distribution and relation to weakness.

  2003cited by this paper
• Physiology of conduction block in multifocal motor neuropathy and other demyelinating neuropathies

  2003cited by this paper
• Efficacy of cyclosporine treatment in multifocal motor neuropathy

  2003cited by this paper
• Consensus criteria for the diagnosis of multifocal motor neuropathy

  2003influential reference
• Multifocal motor neuropathy caused by a B‐cell lymphoma producing a monoclonal IgM autoantibody against peripheral nerve myelin glycolipids GM1 and GD1b

  2003cited by this paper
• Mimic syndromes in sporadic cases of progressive spinal muscular atrophy

  2002cited by this paper
• High-dose cyclophosphamide without stem-cell rescue for refractory CIDP

  2002cited by this paper
• Multifocal motor neuropathy and asymptomatic Hashimoto's thyroiditis: first report of an association.

  2002cited by this paper
• Peripheral neuropathies and anti-glycolipid antibodies.

  2002cited by this paper
• 79(th) ENMC International Workshop: multifocal motor neuropathy. 14-15 April 2000, Hilversum, The Netherlands.

  2001influential reference
• Intravenous immunoglobulin therapy in multifocal motor neuropathy: a double-blind, placebo-controlled study.

  2001cited by this paper
• Multifocal motor neuropathy.

  2001cited by this paper
• 79th ENMC International Workshop: Multifocal motor neuropathy

  2001cited by this paper
• Plasmapheresis in multifocal motor neuropathy: a case report

  2000cited by this paper
• Multifocal inflammatory demyelinating neuropathy: A distinct clinical entity?

  2000cited by this paper
• Treatment of multifocal motor neuropathy with interferon-β1A

  2000cited by this paper
• Treatment of multifocal motor neuropathy with interferon-beta1A.

  2000cited by this paper
• Multifocal motor neuropathy improved by IVIg

  2000cited by this paper
• Natural history of 46 patients with multifocal motor neuropathy with conduction block

  2000cited by this paper
• Multifocal inflammatory demyelinating neuropathy

  2000cited by this paper
• Multifocal motor neuropathy: Diagnostic criteria that predict the response to immunoglobulin treatment

  2000cited by this paper
• Multifocal acquired demyelinating sensory and motor neuropathy: The Lewis–Sumner syndrome

  1999cited by this paper
• Multifocal motor neuropathy and Lewis Sumner syndrome: A clinical spectrum

  1999cited by this paper
• Multifocal motor neuropathy and Lewis Sumner syndrome: Two distinct entities

  1999cited by this paper
• Chronic motor neuropathies: response to interferon-β1a after failure of conventional therapies

  1999cited by this paper
• Central motor conduction time in patients with multifocal motor conduction block

  1999cited by this paper
• Are multifocal motor neuropathy and Lewis–Sumner syndrome distinct nosologic entities?

  1999cited by this paper
• Use of human intravenous immunoglobulin in lower motor neuron syndromes

  1999cited by this paper
• Deterioration of multifocal motor neuropathy after plasma exchange

  1998cited by this paper
• Multifocal motor neuropathy with conduction block misdiagnosed as multiple entrapment neuropathies

  1998cited by this paper
• The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy.

  1998cited by this paper
• Multifocal motor neuropathy without overt conduction block

  1998cited by this paper
• Long term follow up of multifocal motor neuropathy with conduction block under treatment.

  1997cited by this paper
• Long term effect of intravenous immunoglobulins and oral cyclophosphamide in multifocal motor neuropathy

  1997cited by this paper
• Pulsed high‐dose dexamethasone is not effective in patients with multifocal motor neuropathy

  1997cited by this paper
• Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy?

  1997cited by this paper
• Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy

  1997cited by this paper
• The sensitivity and specificity of anti-GM sub 1 antibody testing

  1996cited by this paper
• Sensory nerve pathology in multifocal motor neuropathy

  1996cited by this paper
• Pathological findings in a patient with amyotrophic lateral sclerosis and multifocal motor neuropathy with conduction block.

  1996cited by this paper
• Treatment of multifocal motor neuropathy with high dose intravenous immunoglobulins: a double blind, placebo controlled study.

  1995cited by this paper
• Diagnostic value of GM1 antibodies in motor neuron disorders and neuropathies

  1995cited by this paper
• Multifocal motor neuropathy with conduction block: a study of 24 patients.

  1995cited by this paper
• Intravenous immunoglobulin treatment in patients with motor neuron syndromes associated with anti‐GM1 antibodies

  1994cited by this paper
• Multifocal motor neuropathy: response to human immune globulin.

  1993cited by this paper
• Motor Neuropathy with Multifocal Conduction Block

  1993cited by this paper
• Multifocal motor neuropathy: Response to human immune globulin

  1993cited by this paper
• Peripheral neuropathy: new concepts and treatments.

  1992cited by this paper
• Conduction block in clinical practice

  1991cited by this paper
• Immunosuppressive treatment in multifocal motor neuropathy

  1991cited by this paper
• Chronic acquired demyelinating motor neuropathy

  1991cited by this paper
• Lower motor neuron syndromes defined by patterns of weakness, nerve conduction abnormalities, and high titers of antiglycolipid antibodies

  1990cited by this paper
• A syndrome of asymmetric limb weakness with motor conduction block

  1990cited by this paper
• A computer simulation of conduction block: Effects produced by actual block versus interphase cancellation

  1990cited by this paper
• A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside

  1988cited by this paper
• Multifocal acquired demyelinating neuropathy masqurading as motor neuron disease

  1988cited by this paper
• Slow resolution of multifocal weakness and fasciculation

  1986cited by this paper
• Motor neuropathy with proximal multifocal persistent conduction block, fasciculations and myokymia. Evolution to tetraplegia.

  1986cited by this paper

• In Patients with Dysimmune Motor and Sensorimotor Mononeuropathies, the Degree of Nerve Swelling Correlates with Clinical and Electrodiagnostic Findings

  2026cites this paper
• Blood–Nerve Barrier Breakdown Induced by Immunoglobulin G in Typical and Multifocal Chronic Inflammatory Demyelinating Polyneuropathy and Multifocal Motor Neuropathy

  2026cites this paper
• Prevalence and Patterns of Cranial Nerve Involvement in CIDP, Autoimmune Nodopathy, MMN, and Anti‐MAG Neuropathy: A Multicenter Korea/UK Study of 582 Patients

  2026cites this paper
• Immunotherapies in chronic immune-mediated neuropathies.

  2026cites this paper
• Plasma neurofilament light chain is associated with clinical instability in chronic autoimmune neuropathies.

  2026cites this paper
• Intravenous immunoglobulin use in neurology.

  2026cites this paper
• Monophasic multifocal motor neuropathy with concomitant central nervous system demyelination following anti-TNFα therapy

  2026cites this paper
• Clinical course and prognosis of chronic autoimmune neuropathies requiring intensive care: a retrospective cohort study

  2026cites this paper
• Quantitative MRI of normal brachial plexus and parameters correlations with demographic and anthropometric data.

  2025cites this paper
• Nerve ultrasound in the diagnosis of inflammatory neuropathies.

  2025cites this paper
• Switch from Intravenous to Subcutaneous Immunoglobulin in CIDP and MMN: 12 Months Results from an Observational Study

  2025cites this paper
• Nerve ultrasound of multifocal motor neuropathy, motor and typical chronic inflammatory demyelinating neuropathy.

  2025cites this paper
• Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy

  2025cites this paper
• Criteria for establishing the diagnosis of multifocal motor neuropathy without conduction blocks: a case study

  2025cites this paper
• Feasibility and Reliability of a Monitoring App for Chronic Inflammatory Neuropathies

  2025cites this paper
• Long‐Term Functional Outcomes in Immunoglobulin‐Treated Multifocal Motor Neuropathy Evaluated Through the MMN‐Rasch‐Built Overall Disability Scale

  2025cites this paper
• Variably Defined Conduction Block, Temporal Dispersion and Other Electrophysiological Abnormalities in Multifocal Motor Neuropathy: A Multicentre Study

  2025cites this paper
• Ultrasound Shear Wave Velocity of Peripheral Nerves: A Possible Non‐Invasive Biomarker for Demyelinating Neuropathies

  2025cites this paper
• Thromboembolic risk of intravenous and subcutaneous immunoglobulin treatment for neuroinflammatory diseases

  2025cites this paper
• Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients with Multifocal Motor Neuropathy: A US Claims Database Cohort Study

  2025cites this paper
• Establishing Reference Values in the Neuromuscular Ultrasound Laboratory Using the e‐Norms Method: A Feasibility Study

  2025cites this paper
• Impact of the COVID-19 pandemic on the mental and physical wellbeing of patients with motor neuron disease and other neuromuscular disease

  2025cites this paper
• Involuntary movements in multifocal motor neuropathy: A manifestation of axonal hyperexcitability and motor instability.

  2025cites this paper
• Update on paraproteinemic neuropathy

  2025cites this paper
• Humoral Immune Response Following COVID-19 Vaccination in Multifocal Motor Neuropathy and Chronic Inflammatory Demyelinating Polyneuropathy

  2025cites this paper
• Frequency and Relevance of MYD88L256P Mutation in Chronic Inflammatory Demyelinating Polyradiculoneuropathy and Multifocal Motor Neuropathy

  2025cites this paper
• Multifocal Motor Neuropathy: A Narrative Review

  2025cites this paper
• Comparison of Different Ultrasound Protocols in Patients with Inflammatory Polyneuropathies with Practical Insights

  2025cites this paper
• Immune-mediated Neuropathies in Clinical Practice: A Narrative Review

  2025cites this paper
• Quantitative approach in assessing standard brachial plexus MRI for the diagnosis of multifocal motor neuropathy and Lewis–Sumner syndrome

  2025cites this paper
• Clinical Manifestations and Treatment Responses in Pediatric Neurofascin 155-IgG4 Autoimmune Nodopathy

  2025cites this paper
• Feasibility and Tolerability of Subcutaneous Immunoglobulin via Manual Push Pre‐Filled Syringes for Inflammatory Neuropathies: A Retrospective Cohort Study

  2025cites this paper
• Diagnosis and Management of Multifocal Motor Neuropathy in the United Kingdom: A Multicentre Survey

  2025influential citation
• Controversies in the diagnosis of chronic inflammatory demyelinating polyneuropathy

  2025cites this paper
• Spontaneous muscle activity in multifocal motor neuropathy - Insights from axonal excitability testing.

  2025cites this paper
• Lymphoma-Associated Multifocal Motor Neuropathy With Conduction Block in a Patient Recently Diagnosed With HIV

  2025cites this paper
• Immune-Mediated Neuropathies Other Than Typical Chronic Inflammatory Demyelinating Polyradiculoneuropathy-Multifocal Motor Neuropathy, Autoimmune Nodopathies, Anti-Myelin Associated Glycoprotein Neuropathy, Chronic Inflammatory Sensory Polyradiculoneuropathy, and Chronic Ataxic Neuropathy with Ophth

  2025cites this paper
• The diagnostic utility of magnetic resonance neurography in diagnosis of plexus and peripheral neuropathies compared to electroneurophysiological studies

  2025cites this paper
• [A case of possible multifocal motor neuropathy with suspected posterior interosseous nerve palsy].

  2025cites this paper
• Characteristics, Treatment Patterns, Healthcare Resource Utilization, and Costs Among Patients with Multifocal Motor Neuropathy: A US Claims Database Cohort Study

  2025cites this paper
• IgM Anti-Ganglioside Binding and Complement Activation in an iPSC-Derived Motor Neuron Model for Multifocal Motor Neuropathy

  2025cites this paper
• Complement activation in immunological neurological disorders: mechanisms and therapeutic strategies

  2025cites this paper
• The Study of the Parameters of Diffusion Tensor MRI of Brachial Plexuses and Parameters Correlations with Demographic and Anthropometric Data

  2025cites this paper
• Diagnostic value of neurofilaments in differentiating motor neuron disease from multifocal motor neuropathy

  2024cites this paper
• The role of imaging in focal neuropathies.

  2024cites this paper
• Cytokines and chemokines in patients with chronic inflammatory demyelinating polyradiculoneuropathy and multifocal motor neuropathy: A systematic review

  2024cites this paper
• IgM anti-GM2 antibodies in patients with multifocal motor neuropathy target Schwann cells and are associated with early onset

  2024cites this paper
• Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyneuropathy?

  2024cites this paper
• Semiquantitative assessment of preganglionic nerves for chronic immune-mediated neuropathies using brachial plexus magnetic resonance imaging

  2024cites this paper
• Inter-laboratory comparison of routine autoantibody detection methods for autoimmune neuropathies and myasthenia gravis

  2024cites this paper
• Multifocal motor neuropathy: long-term clinical and electrophysiological features of the disease

  2024cites this paper
• Quantitative MRI assessment of peripheral nerves

  2024cites this paper
• Neuroimaging Markers for Differential Diagnosis Between Multifocal Motor Neuropathy and Multifocal Acquired Demyelinating Sensory and Motor Neuropathy

  2024cites this paper
• A 21‐bp deletion in the complement regulator CD55 promotor region is associated with multifocal motor neuropathy and its disease course

  2024influential citation
• Assessment of diagnostic criteria for multifocal motor neuropathy in patients included in the Italian database

  2024influential citation
• Reply to the Letter to the Editor “Do corticosteroids aggravate pure motor chronic inflammatory demyelinating polyradiculoneuropathy (CIDP)?” by Kokubun N. et al.

  2024cites this paper
• Radial motor nerve conduction study in posterior interosseous nerve syndrome and multifocal motor neuropathy

  2024cites this paper
• Impact of 2021 European Academy of Neurology/Peripheral Nerve Society diagnostic criteria on diagnosis and therapy of chronic inflammatory demyelinating polyradiculoneuropathy variants

  2024cites this paper
• A Practical Guide to Identify Patients With Multifocal Motor Neuropathy, a Treatable Immune-Mediated Neuropathy

  2024cites this paper
• Steroid-responsive multifocal motor neuropathy with cranial manifestations - a case report.

  2024cites this paper
• Neuropatie motorie multifocali con blocco di conduzione

  2024cites this paper
• Prevention of axonal loss after immediate dosage titration of immunoglobulin in multifocal motor neuropathy

  2024cites this paper
• Comparative analysis of albumin quotient and total CSF protein in immune-mediated neuropathies: a multicenter study on diagnostic implications

  2024cites this paper
• Neuropathies motrices multifocales avec bloc de conduction

  2024cites this paper
• Series: Diagnosis at a Glance

  2024cites this paper
• Neuromuscular ultrasound in combination with nerve conduction studies helps identify inflammatory motor neuropathies from lower motor neuron syndromes

  2024cites this paper
• Cervical lower motor neuron syndromes: A diagnostic challenge.

  2024cites this paper
• Complement activation by IgM autoantibodies linked to immune‐mediated neuropathies depends on C2

  2024cites this paper
• Immune-Mediated Neuropathies: Top 10 Clinical Pearls

  2024cites this paper
• Autoantibodies in neuromuscular disorders: a review of their utility in clinical practice

  2024cites this paper
• Multifocal motor neuropathy in Japan: A nationwide survey on prevalence, clinical profiles, and treatment

  2024cites this paper
• Ultrasonographic abnormalities in clinically unaffected nerves of patients with nonvasculitic motor and sensorimotor mononeuropathies

  2024cites this paper
• Immunoglobulin use in neurology: a practical approach

  2024cites this paper
• Antibodies in immune-mediated peripheral neuropathies. Where are we in 2024?

  2024cites this paper
• Comparative multimodal sensory testing in multifocal motor neuropathy and multifocal variant of chronic inflammatory demyelinating polyradiculoneuropathy

  2024cites this paper
• Multifocal motor neuropathy as a mimic of amyotrophic lateral sclerosis: Serum neurofilament light chain as a reliable diagnostic biomarker

  2024cites this paper
• An atypical case of pure motor neuropathy with proximal limb weakness and polyphasic course

  2024cites this paper
• Neurological manifestations of MGUS.

  2024cites this paper
• Assessing hand motor function in chronic immune-mediated neuropathies: a proof-of-concept study using a data glove

  2024cites this paper
• Comparison of the diagnostic accuracy of the 2010 European Federation of Neurological Societies/Peripheral Nerve Society and American Association of Electrodiagnostic Medicine diagnostic criteria for multifocal motor neuropathy

  2024influential citation
• [Clinical features of 8 patients with multifocal motor neuropathy in the long-term follow-up].

  2023cites this paper
• Risk of disease relapse, safety and tolerability of SARS‐CoV‐2 vaccination in patients with chronic inflammatory neuropathies

  2023cites this paper
• Ultra-high dose of intravenous immunoglobulin restores strength and motor function in a patient with refractory multifocal motor neuropathy

  2023cites this paper
• Best practices in the use of human immunoglobulin preparations for intravenous administration in the treatment of rare neurological diseases

  2023cites this paper
• In-line warming reduces in-line pressure of subcutaneous infusion of concentrated immunoglobulins

  2023cites this paper
• Quantitative MR Neurography in Multifocal Motor Neuropathy and Amyotrophic Lateral Sclerosis

  2023cites this paper
• A review on Chronic Inflammatory Demyelinating Polyradiculoneuropathy

  2023cites this paper
• Fatigue, depression, and product tolerability during long-term treatment with intravenous immunoglobulin (Gamunex® 10%) in patients with chronic inflammatory demyelinating polyneuropathy

  2023cites this paper
• Cranial nerve involvement in patients with immune-mediated neuropathy: An observational blink reflex study.

  2023cites this paper
• [The significance of autoantibodies against nodal and paranodal proteins in autoimmune nodopathies].

  2023cites this paper
• Nerve enlargement differs among chronic inflammatory demyelinating polyradiculoneuropathy subtypes and multifocal motor neuropathy

  2023cites this paper
• Validation of elevated levels of interleukin-8 in the cerebrospinal fluid, and discovery of new biomarkers in patients with GBS and CIDP using a proximity extension assay

  2023cites this paper
• Conventional MRI of peripheral nerves: MR-neurography.

  2023cites this paper
• Evidence for spontaneous regulation of the humoral IgM anti‐GM1 autoimmune response by IgG antibodies in multifocal motor neuropathy patients

  2023cites this paper
• Autoimmune polyneuropathies.

  2023cites this paper
• Multifocal motor neuropathy is not associated with altered innate immune responses to endotoxin.

  2023cites this paper
• Epidemiology and Clinical Course of Chronic Autoimmune Neuropathies During the SARS-CoV-2 Pandemic in Latvia

  2023cites this paper
• Contactin-associated protein 2 autoantibodies can be associated with multifocal motor-like neuropathy: a case report

  2023cites this paper
• Chronic Immune-Mediated Demyelinating Neuropathies

  2023cites this paper
• EREDETI KÖZLEMÉNY INVESTIGATION OF OXIDATIVE STRESS IN PATIENTS WITH MULTIFOCAL MOTOR NEUROPATHY

  2022cites this paper